P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of <it>in vitro </it>replication by Derdeyn CA, Gnanakaran S, Allen SA, Mulenga J, Li B, Rong R, Murphy MK

OA06-03. Dynamics of CTL epitope escape and reversion in an African subtype C cohort by Allen S, Kaslow R, Farmer P, Goepfert P, Tang J, Mulenga J, Schaefer M, Hunter E

Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity by Crawford, H, Lumm, W, Leslie, A, Schaefer, M, Boeras, D, Prado, J, Mulenga, J, Allen, S, Goulder, P, Hunter, E

P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity by Crawford, H, Lumm, W, Leslie, A, Schaefer, M, Boeras, D, Prado, J, Mulenga, J, Allen, S, Goulder, P, Hunter, E

Intrasubtype C superinfected individuals mount delayed and low-titer autologous neutralizing antibody responses prior to superinfection by Basu D, Kraft C, Campbell P, Murphy M, Yu T, Hraber P, Chomba E, Mulenga J, Kilembe W, Allen S, Derdeyn C, Hunter E

HLA-A*68:02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective. by Kløverpris, H, Stryhn, A, Harndahl, M, Carlson, J, Leslie, A, Chen, F, Riddell, L, Mulenga, J, Walker, B, Ndung'u, T, Buus, S, Goulder, P

HLA-A*68: 02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective by Kløverpris, H, Stryhn, A, Harndahl, M, Carlson, J, Leslie, A, Chen, F, Riddell, L, Mulenga, J, Walker, B, Ndung'U, T, Buus, S, Goulder, P

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape by Gnanakaran S, Shaw GM, Pinter A, Blackwell JL, Allen SA, Mulenga J, Murphy MK, Haaland RE, Li B, Rong R, Hunter E, Robinson JE, Derdeyn CA

Promotion of couples’ voluntary HIV counseling and testing in Lusaka, Zambia by influence network leaders and agents by Wall K, Kilembe W, Nizam A, Vwalika C, Kautzman M, Chomba E, Tichacek A, Sardar G, Casanova D, Henderson F, Mulenga J, Kleinbaum D, Allen S

Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: a... by Banda, C, Chaponda, M, Mukaka, M, Mulenga, M, Hachizovu, S, Kabuya, J, Mulenga, J, Sikalima, J, Kalilani-Phiri, L, Terlouw, D, Khoo, S, Lalloo, D, Mwapasa, V

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. by Goepfert, P, Lumm, W, Farmer, P, Matthews, P, Prendergast, A, Carlson, J, Derdeyn, C, Tang, J, Kaslow, R, Bansal, A, Yusim, K, Heckerman, D, Mulenga, J, Allen, S, Goulder, P, Hunter, E

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. by Crawford, H, Lumm, W, Leslie, A, Schaefer, M, Boeras, D, Prado, J, Tang, J, Farmer, P, Ndung'u, T, Lakhi, S, Gilmour, J, Goepfert, P, Walker, B, Kaslow, R, Mulenga, J, Allen, S, Goulder, P, Hunter, E

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restrieted gag epitope in chronic human immunodeficien... by Crawford, H, Prado, J, Leslie, A, Hue, S, Honeyborne, I, Reddy, S, van der Stok, M, Mncube, Z, Brander, C, Rousseau, C, Mullins, J, Kaslow, R, Goepfert, P, Allen, S, Hunter, E, Mulenga, J, Kiepiela, P, Walker, B, Goulder, P

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficien... by Crawford, H, Prado, J, Leslie, A, Hué, S, Honeyborne, I, Reddy, S, van der Stok, M, Mncube, Z, Brander, C, Rousseau, C, Mullins, J, Kaslow, R, Goepfert, P, Allen, S, Hunter, E, Mulenga, J, Kiepiela, P, Walker, B, Goulder, P

Adaptation of HIV-1 to human leukocyte antigen class I. by Kawashima, Y, Pfafferott, K, Frater, J, Matthews, P, Payne, R, Addo, M, Gatanaga, H, Fujiwara, M, Hachiya, A, Koizumi, H, Kuse, N, Oka, S, Duda, A, Prendergast, A, Crawford, H, Leslie, A, Brumme, Z, Brumme, C, Allen, T, Brander, C, Kaslow, R, Tang, J, Hunter, E, Allen, S, Mulenga, J

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. by Stevens, W, Kamali, A, Karita, E, Anzala, O, Sanders, E, Jaoko, W, Kaleebu, P, Mulenga, J, Dally, L, Fast, P, Gilmour, J, Farah, B, Birungi, J, Hughes, P, Manigart, O, Stevens, G, Yates, S, Thomson, H, von Lieven, A, Krebs, M, Price, M, Stoll-Johnson, L, Ketter, N

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. by Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A